primary biliary cholangitis
Hepatology · 2018–2025
8decisions
4medicines
6carried consumer input
33individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| elafibranor Primary biliary cholangitis (PBC) in patients with inadequate response to ursodeoxycholic acid (UDCA) or intolerance to UDCA, in combination with UDCA or as… | Mar 2025 | Recommended | 1 individuals Liver Foundation |
| seladelpar Primary biliary cholangitis in patients with inadequate response to ursodeoxycholic acid (UDCA) or intolerance to UDCA. | Dec 2025 | Recommended with restriction | input received Liver Foundation |
| seladelpar Treatment of primary biliary cholangitis in patients with inadequate response to ursodeoxycholic acid (UDCA) or intolerance to UDCA. | Dec 2025 | Recommended with restriction | input received Liver Foundation |
| ursodeoxycholic acid Treatment of primary biliary cholangitis (previously known as primary biliary cirrhosis). This is a request to increase the maximum number of repeats from 2 to… | Mar 2023 | Recommended | input received |
| obeticholic acid Primary biliary cholangitis (previously known as primary biliary cirrhosis) in combination with ursodeoxycholic acid in UDCA inadequate responders and as… | Mar 2021 | Recommended with restriction | none received |
| obeticholic acid Primary biliary cholangitis (PBC) in patients with inadequate response to ursodeoxycholic acid (UDCA) or in patients unable to tolerate UDCA. | Nov 2020 | Deferred | 1 individuals CMH General Association |
| obeticholic acid Treatment of primary biliary cholangitis in adults with inadequate response to ursodeoxycholic acid (in combination with UDCA) or in adults unable to tolerate… | Jul 2019 | Not recommended | 31 individuals |
| obeticholic acid Primary biliary cholangitis in adults with inadequate response to ursodeoxycholic acid (UDCA) or intolerant to UDCA. | Nov 2018 | Not recommended | none received |
Who spoke
Liver Foundation · CMH General Association
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 6 of 8 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.